Cellular phenotypic transitions in diabetic nephropathy: An update

被引:13
|
作者
Cao, Yiling [1 ]
Lin, Ji-Hong [2 ]
Hammes, Hans-Peter [2 ]
Zhang, Chun [1 ]
机构
[1] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Nephrol, Wuhan, Peoples R China
[2] Heidelberg Univ, Med Fac Mannheim, Med Dept 5, Mannheim, Germany
基金
中国国家自然科学基金;
关键词
diabetic nephropathy; phenotypic transition; fibrosis; EMT; EndoMT; signaling pathway; EPITHELIAL-MESENCHYMAL TRANSITION; INTEGRIN-LINKED KINASE; CATENIN SIGNALING PATHWAY; GROWTH-FACTOR; MYOFIBROBLAST TRANSITION; MOLECULAR-MECHANISMS; BETA-CATENIN; INTERSTITIAL FIBROSIS; PODOCYTE DYSFUNCTION; RENAL FIBROSIS;
D O I
10.3389/fphar.2022.1038073
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Diabetic nephropathy (DN) is a major cause of morbidity and mortality in diabetes and is the most common cause of end stage renal disease (ESRD). Renal fibrosis is the final pathological change in DN. It is widely believed that cellular phenotypic switching is the cause of renal fibrosis in diabetic nephropathy. Several types of kidney cells undergo activation and differentiation and become reprogrammed to express markers of mesenchymal cells or podocyte-like cells. However, the development of targeted therapy for DN has not yet been identified. Here, we discussed the pathophysiologic changes of DN and delineated the possible origins that contribute to myofibroblasts and podocytes through phenotypic transitions. We also highlight the molecular signaling pathways involved in the phenotypic transition, which would provide valuable information for the activation of phenotypic switching and designing effective therapies for DN.
引用
收藏
页数:15
相关论文
共 50 条
  • [1] Phenotypic transitions and fibrosis in diabetic nephropathy
    Simonson, M. S.
    KIDNEY INTERNATIONAL, 2007, 71 (09) : 846 - 854
  • [2] Collagen VIII influences epithelial phenotypic changes in experimental diabetic nephropathy
    Loeffler, Ivonne
    Liebisch, Marita
    Wolf, Gunter
    AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2012, 303 (05) : F733 - F745
  • [3] Perspectives on the role of PTEN in diabetic nephropathy: an update
    Khokhar, Manoj
    Roy, Dipayan
    Modi, Anupama
    Agarwal, Riddhi
    Yadav, Dharmveer
    Purohit, Purvi
    Sharma, Praveen
    CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES, 2020, 57 (07) : 470 - 483
  • [4] Molecular mechanisms in the pathogenesis of diabetic nephropathy: An update
    Arora, Mandeep Kumar
    Singh, Umesh Kumar
    VASCULAR PHARMACOLOGY, 2013, 58 (04) : 259 - 271
  • [5] Update on Diabetic Nephropathy 2018
    Boeger, Carsten Alexander
    Kraemer, Bernhard Karl
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2018, 143 (20) : 1460 - 1465
  • [6] The role of cellular crosstalk in the progression of diabetic nephropathy
    Zhang, Keying
    Fu, Zhangning
    Zhang, Yifan
    Chen, Xiangmei
    Cai, Guangyan
    Hong, Quan
    FRONTIERS IN ENDOCRINOLOGY, 2023, 14
  • [7] Update on the Protective Renal Effects of Metformin in Diabetic Nephropathy
    Eisenreich, Andreas
    Leppert, Ulrike
    CURRENT MEDICINAL CHEMISTRY, 2017, 24 (31) : 3397 - 3412
  • [8] Targeted therapies in diabetic nephropathy: an update
    Gupta, Ankur
    Gupta, Preeti
    Biyani, Mohan
    JOURNAL OF NEPHROLOGY, 2011, 24 (06) : 686 - 695
  • [9] Biomarkers of diabetic nephropathy: A 2017 update
    Papadopoulou-Marketou, Nektaria
    Kanaka-Gantenbein, Christina
    Marketos, Nikolaos
    Chrousos, George P.
    Papassotiriou, Ioannis
    CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES, 2017, 54 (05) : 326 - 342
  • [10] Current Update in the Management of Diabetic Nephropathy
    Van Buren, Peter Noel
    Toto, Robert
    CURRENT DIABETES REVIEWS, 2013, 9 (01) : 62 - 77